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Abstract Purified human respiratory syncytial virus (HRSV) P
phosphoprotein from transfected HEp-2 cells is able to
oligomerize forming tetramers. The bulk of constitutive P
protein phosphorylation (99.8%) (serine residues 116, 117, 119,
232 and 237) can be removed without affecting protein
oligomerization. However, dephosphorylated P protein, produced
in bacteria, is unable to oligomerize. This difference can be
explained by a transient P protein phosphorylation, detected in
HEp-2 cells, that could be essential for P protein oligomeriza-
tion.
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1. Introduction
Human respiratory syncytial virus (HRSV) is the most im-
portant respiratory virus worldwide a¡ecting hospitalized chil-
dren, from 0 to 6 months old, and elderly people [1]. The
e¡orts directed to control HRSV infections are opened in
three fronts: vaccines (viral proteins and attenuated live vi-
rus), administration of humanized neutralizing monoclonal
antibodies and developing of antiviral compounds [2^4].
This virus belongs to the paramyxovirus family, pneumovirus
genera. It is an RNA negative strand (15 222 nucleotides long)
enveloped virus with a capacity to encode 11 viral proteins.
The order of the genes is : 3P leader NS1-NS2-N-P-M-SH-G-
F-M2-L trailer 5P. Proteins L, N, P and M2-ORF1 together
with the viral RNA constitute the nucleocapsids, internal vi-
rion components surrounding the M protein, in contact with
the membranous envelope in which the viral glycoproteins F,
G and SH are inserted. The rest of the proteins are non-struc-
tural [1].
To determine the functions of the viral proteins that con-
stitute the nucleocapsids should be important to obtain atte-
nuated vaccines and to design antiviral compounds because
these viral components are the functional units for viral tran-
scription and replication and the cores of the viral particles.
We are focused on P protein from the Long strain. This
protein is 241 amino acids long and is constitutively
phosphorylated at serines 116, 117 and/or 119 (18.9%) in
the central domain and at serines 232 (78.9%) and 237 (2%)
in the C-terminal domain [5^8]. The main of this phosphory-
lation (98%) can be removed without a¡ecting the protein
functionality for viral transcription and replication [8,9].
However, that phosphorylation seems to be essential for the
morphogenetic pathway of the virion from the formation of
the nucleocapsids [9].
In other Paramyxoviruses as Sendai (SeV) and vesicular
stomatitis (VSV) viruses, the corresponding P proteins have
been characterized as oligomers (trimers and tetramers, re-
spectively), oligomerization being essential for P protein func-
tionality. For SeV, P protein phosphorylation is dispensable
for oligomerization because bacterially expressed protein is a
trimer [10]. In the case of VSV P protein, phosphorylation has
been demonstrated to be essential for P protein tetrameriza-
tion [11]. For HRSV P protein, it has been indicated that
oligomers (trimers or tetramers) are formed when the protein
is expressed in bacteria, precluding a role of phosphorylation
in the P monomers association [12].
In this paper, it is demonstrated that P protein, transient
expressed in HEp-2 cells, is a tetramer. These oligomers can
be formed when 99.8% of the constitutive phosphorylation
has been removed by changing the phosphorylatable serine
residues by alanines. However, in contrast to other results
[12], P protein expressed in bacteria is unable to oligomerize.
These results suggest that the unphosphorylated P protein
produced in HEp-2 cells could have a transitory phosphory-
lation that does not take place in bacteria. This transitory
phosphorylation that occurs at di¡erent residues than those
constitutively phosphorylated has been identi¢ed in HEp-2
cells by using phosphatases inhibitors. In this work, we tested
the possible relation between P protein phosphorylation and
oligomerization.
2. Materials and methods
2.1. P protein variants
All the P protein variants used in this paper, except VP3-10, have
been previously described and characterized [7,8].
VP3-10 was obtained as VP3-8 [8], but using the large fragment
NcoI-NcoI of VP10 instead of that of VP8.
The conditions used for transfection experiments, 32P labelling and
the immunopuri¢cation of P protein have been described [8]. When
the transfected labelled cultures were treated with okadaic acid,
100 nm okadaic acid was added together with [32P]orthophosphate
and the cells were processed as it was indicated above.
2.2. Filtration chromatography
Sephadex G-100 and G-200 columns of 2 ml (7U0.5 cm) were
packed following the manufacturer’s conditions in bu¡er (10 mM
Tris^HCl pH 7.5, 140 mM NaCl, 5 mM EDTA and 1% Triton X-
100).
Immunopuri¢ed P protein in a volume of 150 Wl was chromato-
graphed in the bu¡er indicated. Fifty fractions of 40 Wl were collected.
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P protein was detected by determining its associated radioactivity or
after sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and staining. The columns were calibrated by ¢ltration
of Dextran blue, bovine serum albumin (BSA) and puri¢ed immuno-
globulin G. The chromatographed proteins were detected after SDS^
PAGE analyses of the di¡erent fractions and staining.
2.3. Crosslinking assays
The crosslinking conditions have been described [13]. Brie£y, im-
munopuri¢ed P protein (0.5^1 Wg, with approximately 2000 cpm 32P
Cerenkov) was put in bu¡er: 20 mM HEPES (KOH) pH 7.4, 100 mM
NaCl, 0.1 mM DTT and 1.2 mM MgCl2. Glutaraldehyde, freshly
diluted, was added to 0.025% ¢nal concentration. At di¡erent times,
0, 15 and 30 min, aliquots were removed and 200 mM glycine pH 7.0
(¢nal concentration) and SDS^PAGE sample bu¡er were added. The
samples were ¢nally analyzed in 10% SDS^PAGE.
2.4. Production of P protein in bacteria
A cDNA corresponding to Long strain P protein was obtained by
PCR using as template the cDNA Long P protein gene cloned in the
SmaI site of pGEM3 plasmid, as already described [8]. The following
synthetic oligonucleotides were used in order to leave the ¢rst methio-
nine-coded triplet upstream a canonical Shine^Dalgarno [14] sequence
and to remove the extra non-coding region located after P protein
C-terminal phenylalanine.
5P-GGGATCCGGAGGTGCATCATGG-3P mRNA polarity; 5P-
CCCTGCAGTCAGAAATCTTCAAGTG-3P vRNA polarity.
The underlined nucleotides corresponded to the sequences recog-
nized by restriction enzymes BamHI and PstI (mRNA and vRNA
polarities, respectively) used in the cloning processes, that are absent
in the P protein gene. The initiation and stop codon, respectively, are
indicated by bold letters. The Shine^Dalgarno sequence is indicated
by italic letters.
The cDNA obtained was, after digestion with BamHI and PstI,
cloned in pGEM3 vector digested with the restriction enzymes men-
tioned above.
3. Results
3.1. Immunopuri¢ed P protein is an oligomer with a molecular
weight equal or higher than 1U105 kDa
The HRSV P protein was transient expressed in HEp-2
cells, in the vaccinia vTF-3 based system, and labelled with
32P following previously described conditions [8]. From the
corresponding cellular extract, the labelled P protein was im-
munopuri¢ed and analyzed by SDS^PAGE and autoradiog-
raphy. In Fig. 1A, lane 2, it can be appreciated that the cells
transfected with the plasmid pGEM3-P express a phosphory-
lated protein that is absent in the cell extract transfected with
the plasmid pGEM3 (lane 1) and that it is immunopuri¢ed by
the anti-P monoclonal antibody 73/P (lane 4). More of 90% of
the radioactivity present in the immunopuri¢ed fraction cor-
responds to P protein and its apparent molecular mass is 33^
36 kDa.
To determine if the immunopuri¢ed P protein displays
some grade of oligomerization, it was chromatographed
through a Sephadex G-100 super¢ne column. This column
can fractionate globular proteins with a relative molecular
mass between 4000 and 150 000. The void volume of the col-
umn was determined by ¢ltration of Dextran blue and it is
indicated by an arrow. P protein, detected by radioactivity,
was found to be present in the same fractions as Dextran blue
(Fig. 1A). This result indicates that P protein was an oligomer
because according to its molecular mass (33^36 kDa), it must
be included in the column. Its presence in the void volume
indicates an apparent molecular mass of about 1^1.5U105 or
higher. It is compatible with the presence of three or four P
protein monomers in that fraction.
3.2. Immunopuri¢ed P protein is a tetramer
In order to determine the presence of three or four mono-
mers in the immunopuri¢ed P protein oligomer, immunopuri-
¢ed P protein was chromatographed through a Sephadex G-
Fig. 1. P protein transiently expressed in HEp-2 cells is a tetramer.
P protein was transiently expressed in HEp-2 cells with the vaccinia
recombinant expression-based system by using pGEM3-P recombi-
nant plasmid [8] (A, lanes 2 and 4 of the inset). The transfection
was also done with the plasmid pGEM3 as control (A, lanes 1 and
3 of the inset). The transfected cells were labelled with
[32P]orthophosphate and cell extracts were prepared [8]. The cell ex-
tracts were analyzed by SDS^PAGE before (A, lanes 1 and 2 of the
insert) and after (A, lanes 3 and 4 of the insert) immunochromatog-
raphy through a column containing covalently bound anti-P mono-
clonal antibody 73/P. The immunopuri¢ed P protein was chromato-
graphed through a Sephadex G-100 column and its presence was
followed by determining radioactivity in the collected fractions. The
void volume, Vo, was determined by ¢ltration of Dextran blue (A).
B: The immunopuri¢ed P protein was chromatographed through a
Sephadex G-200 column and its presence was followed by determi-
nation of radioactivity in the di¡erent fractions and SDS^PAGE of
the fractions containing the radioactivity peak. P protein was de-
tected by autoradiography (B, upper part of the inset) and silver
staining (B, lower part of the inset). The elution position was deter-
mined by comparing with those of puri¢ed immunoglobulin G and
BSA. C: The immunopuri¢ed P protein was incubated with glutar-
aldehyde as is indicated in Section 2. At di¡erent times of incuba-
tion, 0, 5, 15 and 30 min, aliquots were removed and after stopping
the reaction by addition of 0.2 M glycine and SDS sample bu¡er,
analyzed in SDS^PAGE 10% acrylamide gels. The autoradiography
of the resulting gel is shown, indicating the electrophoretical mobili-
ties of molecular weight markers and the position, and relative mo-
lecular mass, determined for the di¡erent P protein oligomers.
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200 column calibrated with serum albumin and with puri¢ed
immunoglobulin G. The pro¢le of radioactivity in the column
is shown in Fig. 1B and the position of the marker proteins,
determined after SDS^PAGE and staining with Coomassie
blue, is indicated. The presence of P protein in the di¡erent
fractions was further detected by autoradiography (Fig. 1B,
upper part of inset).
It can be observed that P protein appears in the same frac-
tions as immunoglobulin G, indicating an apparent molecular
mass of about 1.5U105. Thus, it seems that P protein is a
tetramer.
In order to determine if only phosphorylated P protein is
oligomerized, the gel, in which the protein present in the dif-
ferent fractions was characterized, was silver-stained (Fig. 1B,
lower part of inset). A correlation between 32P labelling and
mass of P protein was found. The presence of minor amounts
of P protein present in the included volume of the column
indicates that not all the immunopuri¢ed P protein is in the
oligomerized form and that some monomers, and perhaps
some dimers, could also be present.
3.3. Tetramerization of P protein can also be demonstrated by
crosslinking of the protein
Because in the P protein immunopuri¢cation by a⁄nity
chromatography, through Sepharose 4B with covalent bound
anti-P monoclonal antibody 73/P, the protein is eluted with
Fig. 2. P protein constitutive phosphorylation is not essential for oligomerization. A: Amino acid sequence of HRSV P protein Long strain
[20], showing in bold letters the mutated serines in the di¡erent P protein variants. B: Diagram representation of P protein Long strain show-
ing its serine residues and their substitution in the di¡erent variants VP assayed for oligomerization. The speci¢c activity and behavior in exclu-
sion chromatographies and crosslinking experiments of the di¡erent variants are indicated at the right part of the ¢gure.
Fig. 3. P protein-regulated phosphorylation could be essential for oligomerization. A: P protein was controlled expressed in bacteria and in
HEp-2 cells. The corresponding extracts were crosslinked with glutaraldehyde and, at di¡erent times, samples were removed and analyzed by
Western blot with anti-P rabbit sera. The symbols 3 and + correspond to bacterial extract protein fraction from non-induced or induced cells,
respectively. The position of the molecular weight markers and those of the di¡erent P protein oligomers are indicated at the right margin of
the ¢gure. The position of P protein from puri¢ed viral particles (lane V) is indicated at the left margin of the ¢gure. B: Immunopuri¢ed P
protein transient expressed in the presence (+) or in the absence (3) of okadaic acid (OKA) detected by autoradiography (32P) and Western
blot (W) with anti-P rabbit sera. C: Autoradiography of immunopuri¢ed VP (lanes 1), VP3-8 (lanes 2) and VP3-10 (lanes 3) proteins from
transfected HEp-2 cells, labelled with 32P in the absence (3) or in the presence (+) of okadaic acid (OKA).
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0.1 M glycine pH 2.5, it was possible to argue that immuno-
puri¢ed P protein was denatured and that the behavior in the
¢ltration chromatographies should be due to a loss of its
hypothetical globular structure more than to its oligomeriza-
tion. To clarify that point, glutaraldehyde crosslinking experi-
ments with immunopuri¢ed P protein were done. Fig. 1C,
shows that P protein, after 5 min of incubation with glutar-
aldehyde, generates three phosphorylated polypeptides with a
higher molecular mass than that of P protein. According to
the molecular mass of the stained molecular weight markers,
their molecular masses correspond to 76 000, 148 000 and
higher than 207 000 kDa. These results indicate that glutaral-
dehyde is able to covalently link two (dimer), four (tetramer)
and probably eight or more (two or more tetramers) P pro-
teins. The absence of trimers is noteworthy .
3.4. The oligomerization is independent of the bulk of P protein
phosphorylation
To probe if P protein phosphorylation is essential for oli-
gomerization, di¡erent P protein variants, containing changes
at the serines phosphorylated in di¡erent combinations, listed
in Fig. 2, were transiently expressed in HEp-2 cells, labelled
with 32P or [35S]methionine and immunopuri¢ed. The speci¢c
activities of the di¡erent P protein variants, referred to as P
protein, are indicated in Fig. 2, and correspond to those de-
scribed previously [7,8], except for the new P protein variant
VP3-10, not described before, which is mainly in the unphos-
phorylated form (0.02% of P protein phosphorylation; data
not shown).
All these variants were chromatographed through a Sepha-
dex G-100 column and the behavior of each of the di¡erent
P proteins was inferred from the radioactivity elution pro¢les.
For the P protein variants with lower levels of phosphory-
lation, VP8 (30%), VP10 (20%), VP3-8 (2%) and VP3-10
(0.2%) ([8] and this paper), the elution of corresponding
P proteins was determined after SDS^PAGE analyses of the
protein present in the di¡erent fractions.
In all cases, the di¡erent P proteins are present in the frac-
tions from the excluded volume of the column, although in
the cases of the P protein variants VP5, VP6 and VP7, one
peak of radioactivity was also found to be present in the
included volume of the column (Fig. 2).
In addition, for VP7, not a clear excluded radioactivity
peak was observed. These results indicate that these protein
variants, mainly VP7, oligomerized less than the normal
P protein.
All P protein variants, except VP7, can crosslink with glu-
taraldehyde acid into tetramers (Fig. 2), more or less in the
same extension than the normal P protein, but VP5 and VP6
variants showed a 40^60% decrease in the formation of olig-
omers (Fig. 2). These results suggest that P protein amino acid
residues located between the positions 99 and 161 are impor-
tant for tetramer formation, the serine at position 99 being
critical.
Both kinds of experiments indicate that 99.8% of the
P protein constitutive phosphorylation is not essential for
P protein oligomerization.
3.5. P protein expressed in bacteria is unable to oligomerize
In order to probe if P protein phosphorylation is dispensa-
ble for the oligomerization, as the previous experiments indi-
cate, P protein was regulated expressed in Escherichia coli
BDE-32 transformed with a plasmid pGEM3 recombinant
that contained the Long strain P protein gene, without non-
coding sequences and a canonical Shine^Dalgarno sequence,
as it is indicated in Section 2.
Transformed bacteria were grown in M9 media at an OD at
590 nm of 0.5 and an equal volume of the culture was or was
not induced with 1 mM IPTG for 180 min. Then, bacterial
extracts were prepared [15] and the proteins present in those
extracts were separated by SDS^PAGE, transferred to Immo-
bilon membranes and analyzed by Western blot with a mono-
speci¢c anti-P rabbit serum. In the extract of the IPTG-in-
duced bacteria, a protein, with the electrophoretical mobility
of P protein, was detected and was absent in the non-induced
bacteria extract (see below, Fig. 3). The bacterial expressed
P protein was barely recognized, in immunoprecipitation
assays, by anti-P 73/P and 1/P monoclonal antibodies and
monospeci¢c sera anti-P or anti-P peptides. Thus, a crosslink-
ing experiment was carried out with the total bacterial extract.
As control, an extract from HEp-2 cells in which P protein
was transiently expressed was included. P protein and its olig-
omers were detected after Western blot with the anti-P rabbit
sera.
It can be observed in Fig. 3A that in transformed E. coli
cells, under induction (lane 0, +) conditions, there is a protein,
absent under non-induction conditions (lane 0 3), recognized
by anti-P sera. This protein has the same electrophoretical
mobility as the P protein transiently expressed in HEp-2 cells
and present in puri¢ed HRSV virions (lane V). Both proteins
are recognized by the anti-P sera. After 5, 15 and 30 min of
incubation with glutaraldehyde, it is clear that the P protein
expressed in HEp-2 cells oligomerizes but the P protein ex-
pressed in E. coli does not. Thus, it seems that the P protein
expressed in bacteria and the P protein variant VP3-10 pro-
duced in HEp-2 cells show di¡erent characteristics although
both are in unphosphorylated form. Two possibilities, among
others, can explain these results : 0.02% of the P protein phos-
phorylation (the level of phosphorylation of the VP3-10 var-
iant) may be enough to allow P protein oligomerization or a
regulated and dynamic phosphorylation at di¡erent residues
than those constitutively phosphorylated, could take place in
HEp-2 cells but not in bacteria cells and it could be respon-
sible for oligomerization, if it is the case, the use of phospha-
tase inhibitors like okadaic acid [16] could indicate the exis-
tence of such a mode of regulated and not constitutive
phosphorylation.
3.6. A new phosphorylated form of P protein appears in
transfected HEp-2 cells treated with okadaic acid
To study if P protein phosphorylation is controlled by cel-
lular protein phosphatases, P protein was transiently ex-
pressed in HEp-2 cells treated or untreated with okadaic
acid, and labelled with [32P]orthophosphate. In both cases,
P protein was immunopuri¢ed.
In the presence of okadaic acid, in addition to P protein, a
new phosphorylated protein with slower electrophoretical mo-
bility than that of P protein was immunopuri¢ed (Fig. 3B). In
order to assure the identity of the new protein, a Western blot
analysis was developed using a monospeci¢c anti-P rabbit
serum. The phosphorylated protein with lower electrophoret-
ical mobility was recognized by the serum (Fig. 3B). It is clear
that the proteins, with the normal and the slower electropho-
retical mobility, obtained in HEp-2 cells treated with okadaic
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acid are both P protein because they are immunopuri¢ed and
are recognized by anti-P monoclonal antibody and the mono-
speci¢c P antibody, respectively. This result indicates that new
phosphorylations controlled by cellular protein phosphatases
PP1 and PP2A [16] could occur when P protein is transiently
expressed in HEp-2 cells.
To know if this regulated phosphorylation occurs in P pro-
tein residues di¡erent to those modi¢ed in a constitutive way,
phosphorylation of all P protein variants was carried out in
the presence and in the absence of okadaic acid. Fig. 3C
shows the results obtained for VP3-8 and VP3-10 variants.
Both P protein variants increase their phosphorylation level
in the presence of okadaic acid. Since those variants lack
serines at positions 116, 117, 119, 232 and 237, novel residues
should be modi¢ed and their dephosphorylation prevented by
okadaic acid.
4. Discussion
The paramyxoviruses phosphorylated P protein is a struc-
tural component of the viral nucleocapsids required for the
viral polymerase activity in order to carry out viral RNA
transcription and replication. The best studied paramyxovi-
ruses P protein is that of SeV, the mouse counterpart of hu-
man parain£uenza virus. Due to the large size of the L poly-
merase (about 2165 amino acids long, in HRSV A2 strain), it
is though that all the functions required for RNA synthesis
are carried on by this viral protein. P protein acts as an es-
sential cofactor that stabilizes L protein, facilitating its func-
tion on viral RNA synthesis and locating L protein on the N-
RNA template. Also, interactions between P protein and N
protein could be important for RNA synthesis, because, as a
consequence of it, N protein remains in the soluble active
form required for viral RNA encapsidation. Also, P protein
is responsible for the addition of new P protein molecules to
the RNA-N protein template that could facilitate the elonga-
tion process during RNA synthesis [17,18].
SeV P protein is a trimer and the domain for oligomeriza-
tion (amino acids 344^411) forms a region with a predicted
coiled-coil structure conserved through the paramyxoviridiae
family. Thus, it seems that trimerization is a general property
of all the paramyxovirus P proteins [19].
For SeV P protein oligomerization, its phosphorylation is
dispensable because P protein produced in bacteria is also a
trimer. The formation of the trimer is essential in that case for
the binding of P protein to the RNA-N protein template [17].
This general role has also been suggested for HRSV P pro-
tein because P protein produced in bacteria has been found to
form aggregates determined by Sephadex G-200 column ¢ltra-
tion [12]. This result is in contrast with that present in this
paper, indicating that P protein produced in bacteria is unable
to oligomerize in crosslinking assays. This assay avoids any
misinterpretation of the results obtained by exclusion chroma-
tography in which protein denaturation could promote pro-
tein aggregation. On the other hand, P protein produced in
mammalian cells behaves as a tetramer, as determined by both
exclusion chromatography and crosslinking experiments. The
absence of trimers indicates that monomers form dimers and
the dimers could oligomerize. Thus the regions that interact
among dimers are not recognized for monomers to form
trimers.
That indicates that pneumoviruses may be di¡erent to the
rest of the paramyxovirus, as also suggested by other features,
as its di¡erent gene order and its increased number of genes
[1]. About the region involved in P protein oligomerization,
we found that VP5 shows a 60% decrease in oligomerization
capacity with respect to that of VP. VP5 contains all the
mutated residues present in VP3 and VP4, two variants with
similar oligomerization capacity to that of VP. Thus, it seems
that the simultaneous mutations of serines 116, 117, 119, 156
and 161 alter the oligomerization domain of P protein. An
additional mutation at serine 143 (variant VP6) further de-
creases by 20% the oligomerization capacity of P protein
and the addition of a mutation in serine 99 (VP7) totally
abolishes the oligomerization of P protein. Then, these results
suggest that the region comprising residues 99^165 is impor-
tant for P protein oligomerization.
When 99.8% of HRSV P protein constitutive phosphory-
lation is removed by substituting the phosphorylatable serines
by alanines, it was found that the corresponding P protein
variant (VP3-10) was able to oligomerize. Because of the dif-
ferent results obtained with unphosphorylated P protein, iso-
lated from mammalian cells or bacteria, we postulate that a
di¡erent modi¢cation like a transient phosphorylation was
occurring in P protein expressed in mammalian cells. In
fact, a new type of phosphorylation strongly controlled by
cellular phosphatases has been detected. This phosphorylation
also occurs in HRSV-infected HEp-2 cells (data not shown)
and it can explain the P protein oligomerization observed in
eukaryotic cells in those P protein variants devoid of their
constitutive phosphorylatable serines.
The phosphatase-controlled P protein phosphorylation
seems to be essential for oligomerization. In this way, it is
possible to speculate that this phosphorylation produces a
conformational change that could be essential for interaction
among P protein monomers. After the oligomerization pro-
cess, this phosphorylation could be removed, leaving P pro-
tein assembled in a tetramer form.
Now, experiments are in progress trying to get oligomeriza-
tion of bacterially expressed P protein after incubating it with
extracts of uninfected HEp-2 cells, as sources of kinases. Also,
directed mutagenesis will be done to determine the P protein
residue modi¢ed by that phosphorylation that may allow
P transition from P protein monomers to P protein tetramers.
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